Inventor
JARED GOLLOB
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C12NMicroorganisms or enzymes25%
A61MDevices for introducing media into, or onto, the body8%
PatentTitleYear
12,171,768IRAK4 degraders and uses thereof202412,031,133GNAQ targeted dsRNA compositions and methods for inhibiting expression202411,827,883Dosages and methods for delivering lipid formulated nucleic acid molecules202311,806,360Compositions and methods for treating transthyretin (TTR) mediated amyloidosis2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to ALNYLAM PHARMACEUTICALS INC (3)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to KYMERA THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 3 | 2023–2024 |
| KYMERA THERAPEUTICS INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2024 |